Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

PURPOSE: Trials of tocilizumab in patients with severe COVID-19 pneumonia have demonstrated mixed results, and the role of tocilizumab in combination with other treatments is uncertain. Here we evaluated whether tocilizumab plus remdesivir provides greater benefit than remdesivir alone in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosas, Ivan O., Diaz, George, Gottlieb, Robert L., Lobo, Suzana M., Robinson, Philip, Hunter, Bradley D., Cavalcante, Adilson W., Overcash, J. Scott, Hanania, Nicola A., Skarbnik, Alan, Garcia-Diaz, Julia, Gordeev, Ivan, Carratalà, Jordi, Gordon, Oliver, Graham, Emily, Lewin-Koh, Nicholas, Tsai, Larry, Tuckwell, Katie, Cao, Huyen, Brainard, Diana, Olsson, Julie K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490137/
https://www.ncbi.nlm.nih.gov/pubmed/34609549
http://dx.doi.org/10.1007/s00134-021-06507-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490137/
https://www.ncbi.nlm.nih.gov/pubmed/34609549
http://dx.doi.org/10.1007/s00134-021-06507-x

Ejemplares similares